title: Fish oil intake compared with olive oil intake in late pregnancy and asthma in the offspring: 16 y of registry-based follow-up from a randomized controlled trial.
abstract: BACKGROUND
  Evidence suggests that asthma is rooted in the intrauterine environment and that intake of marine n-3 polyunsaturated fatty acids (n-3 PUFAs) in pregnancy may have immunomodulatory effects on the child.
  
  
  OBJECTIVE
  Our aim was to examine whether increasing maternal intake of n-3 PUFAs in pregnancy may affect offspring risk of asthma.
  
  
  METHODS
  In 1990, a population-based sample of 533 women with normal pregnancies were randomly assigned 2:1:1 to receive four 1-g gelatin capsules/d with fish oil providing 2.7 g n-3 PUFAs (n = 266); four 1-g, similar-looking capsules/d with olive oil (n = 136); or no oil capsules (n = 131). Women were recruited and randomly assigned around gestation week 30 and asked to take capsules until delivery. Among 531 live-born children, 528 were identified in registries and 523 were still alive by August 2006. Diagnoses from the International Coding of Diseases version 10 were extracted from a mandatory registry that recorded diagnoses reported from hospital contacts.
  
  
  RESULTS
  During the 16 y that passed since childbirth, 19 children from the fish oil and olive oil groups had received an asthma-related diagnosis; 10 had received the diagnosis allergic asthma. The hazard rate of asthma was reduced by 63% (95% CI: 8%, 85%; P = 0.03), whereas the hazard rate of allergic asthma was reduced by 87% (95% CI: 40%, 97%; P = 0.01) in the fish oil compared with the olive oil group.
  
  
  CONCLUSIONS
  Under the assumption that intake of olive oil in the dose provided here was inert, our results support that increasing n-3 PUFAs in late pregnancy may carry an important prophylactic potential in relation to offspring asthma.
authors.affiliation: Maternal Nutrition Group, Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark. sfo@ssi.dk
authors.forename: Sjurdur F
authors.initials: SF
authors.lastname: Olsen
authors.forename: Marie Louise
authors.initials: ML
authors.lastname: Østerdal
authors.forename: Jannie Dalby
authors.initials: JD
authors.lastname: Salvig
authors.forename: Lotte Maxild
authors.initials: LM
authors.lastname: Mortensen
authors.forename: Dorte
authors.initials: D
authors.lastname: Rytter
authors.forename: Niels J
authors.initials: NJ
authors.lastname: Secher
authors.forename: Tine Brink
authors.initials: TB
authors.lastname: Henriksen
mesh_terms: D000293:Adolescent; D000328:Adult; D001249:Asthma / Q000175:diagnosis* / Q000453:epidemiology*; D019587:Dietary Supplements; D015525:Fatty Acids, Omega-3 / Q000008:administration & dosage* / Q000494:pharmacology; D005260:Female; D005395:Fish Oils / Q000008:administration & dosage* / Q000494:pharmacology; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D039382:Maternal Nutritional Physiological Phenomena / Q000502:physiology*; D000069463:Olive Oil; D010938:Plant Oils; D011247:Pregnancy; D011297:Prenatal Exposure Delayed Effects; D012042:Registries
chemical_list: D015525:Fatty Acids, Omega-3; D005395:Fish Oils; D000069463:Olive Oil; D010938:Plant Oils